Skip to main navigation Skip to search Skip to main content

Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C

  • Kazuhiko Mishima
  • , Ryo Nishikawa
  • , Yoshitaka Narita
  • , Junki Mizusawa
  • , Minako Sumi
  • , Tomoyuki Koga
  • , Nobuyoshi Sasaki
  • , Manabu Kinoshita
  • , Motoo Nagane
  • , Yoshiki Arakawa
  • , Koji Yoshimoto
  • , Ichiyo Shibahara
  • , Naoki Shinojima
  • , Kenichiro Asano
  • , Takao Tsurubuchi
  • , Hikaru Sasaki
  • , Akio Asai
  • , Takashi Sasayama
  • , Yasutomo Momii
  • , Atsushi Sasaki
    • Shigeo Nakamura, Masaru Kojima, Jun Ichi Tamaru, Kazuhiro Tsuchiya, Miho Gomyo, Kayoko Abe, Manabu Natsumeda, Fumiyuki Yamasaki, Hiroshi Katayama, Haruhiko Fukuda

Research output: Contribution to journal › Article › peer-review

26   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry